Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma
- 19 July 2014
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 41 (11) , 2008-2016
Abstract
It has been suggested that FDG PET has predictive value for the prognosis of treated oesophageal carcinoma. However, the studies reported in the literature have shown discordant results. The aim of this study was to determine whether pretherapy quantitative metabolic parameters correlate with patient outcomes. Included in the study were 67 patients with a histological diagnosis of oesophageal squamous cell carcinoma. Each patient underwent 18F-FDG PET (4.5 MBq/kg) before chemoradiotherapy. Quantitative analysis was performed using the following parameters: age, weight loss, location, N stage, OMS performance status, MTVp and MTVp′ (metabolic tumour volume determined by two different physicians), MTV40% (volume for a threshold of 40 % of SUVmax), MTVa (volume automatically determined with a contrast-based adaptive threshold method), SUVmax, SUVmean and TLG (total lesion glycolysis). MTVp and MTV40% were highly correlated (Pearson’s index 0.92). SUVmeanp and SUVmean40% were also correlated (Pearson’s index 0.86), as were TLGp and TLG40% (Pearson’s index 0.98). Similarly, the parameters obtained with the adaptive threshold method (MTVa, SUVmeana and TLGa) were correlated with those obtained manually (MTVp, SUVmeanp and TLGp). The manual metabolic tumour volume determination (MTVp and MTVp′) was reproducible. Multivariate analysis for disease-free survival (DFS) showed that a larger MTVp was associated with a shorter DFS (p = 0.004) and that a higher SUVmax was associated with a longer DFS (p = 0.02). Multivariate analysis for overall survival (OS) showed that a larger MTVp was associated with a shorter OS (p = 0.01) and that a tumour in the distal oesophagus was associated with a longer OS (p = 0.005). The associations among the other parameters were not statistically significant. Metabolic tumour volume is a major prognostic factor for DFS and OS in patients with oesophageal squamous cell carcinoma. Higher SUVmax values were paradoxically associated with longer survival. The location of the tumour also appeared to affect prognosis.Keywords
This publication has 41 references indexed in Scilit:
- Prognostic significance of lymph node characteristics on survival in esophageal squamous cell carcinomasWiener klinische Wochenschrift, 2013
- 18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinomaDigestive and Liver Disease, 2012
- Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, CanadaBMC Cancer, 2011
- FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A ReviewAnnals of Surgical Oncology, 2011
- Correlation of 18F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancerNuclear Medicine Communications, 2009
- Development of a generic thresholding algorithm for the delineation of18FDG-PET-positive tissue: application to the comparison of three thresholding modelsPhysics in Medicine & Biology, 2009
- Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal CarcinomaAnnals of Surgical Oncology, 2009
- Staging investigations for oesophageal cancer: a meta-analysisBritish Journal of Cancer, 2008
- Is Surgery Still Part of Local Therapy in Patients With Locally Advanced Esophageal Carcinoma?Journal of Clinical Oncology, 2007